{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:52:52Z","timestamp":1788310372940,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["NIAAA K08 T26-1616-11"],"award-info":[{"award-number":["NIAAA K08 T26-1616-11"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI104870"],"award-info":[{"award-number":["R01AI104870"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI104870"],"award-info":[{"award-number":["R01AI104870"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI104870"],"award-info":[{"award-number":["R01AI104870"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-00828-4","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:53:13Z","timestamp":1746201193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamics"],"prefix":"10.1038","volume":"5","author":[{"given":"Nadia","family":"Siles Alvarado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisey","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8986-9762","authenticated-orcid":false,"given":"Cole","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzifa A.","family":"Amengor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1268-7164","authenticated-orcid":false,"given":"Annalee W.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Wilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine","family":"Caslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4112-6005","authenticated-orcid":false,"given":"Christopher","family":"DiPasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Abigania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle","family":"Creaturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9905-8871","authenticated-orcid":false,"given":"Kerin","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5494-6510","authenticated-orcid":false,"given":"Todd A.","family":"Triplett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-9124","authenticated-orcid":false,"given":"Justin F.","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Strakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-8486","authenticated-orcid":false,"given":"Jennifer A.","family":"Maynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1697-1755","authenticated-orcid":false,"given":"Lauren I. R.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-3591","authenticated-orcid":false,"given":"Esther","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"828_CR1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. WHO Health Emergency Dashboard. 2023 [cited 2023 Jan 3]. https:\/\/covid19.who.int\/"},{"key":"828_CR2","unstructured":"CDC. COVID Data Tracker: COVID-19 Vaccinations in the United States [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2023 Jun 27]. https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccination-states-jurisdictions"},{"key":"828_CR3","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1016\/S1473-3099(22)00311-5","volume":"22","author":"D Focosi","year":"2022","unstructured":"Focosi, D. et al. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect. Dis. 22, e311\u2013e326 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"828_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jiph.2020.07.001","volume":"13","author":"MA Chowdhury","year":"2020","unstructured":"Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. D. A. & Alam, A. Immune response in COVID-19: A review. J. Infect. Public Health 13, 1619\u20131629 (2020).","journal-title":"J. Infect. Public Health"},{"key":"828_CR5","doi-asserted-by":"publisher","first-page":"1557.e1","DOI":"10.1016\/j.cmi.2020.07.038","volume":"26","author":"J Van Elslande","year":"2020","unstructured":"Van Elslande, J. et al. Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs. Clin. Microbiol Infect. 26, 1557.e1\u20131557.e7 (2020).","journal-title":"Clin. Microbiol Infect."},{"key":"828_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju, B. et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature 584, 115\u2013119 (2020).","journal-title":"Nature"},{"key":"828_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107893","volume":"98","author":"G Moradi","year":"2021","unstructured":"Moradi, G. et al. Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: a prospective longitudinal cohort study. Int. Immunopharmacol. 98, 107893 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"828_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100734","volume":"32","author":"S Yamayoshi","year":"2021","unstructured":"Yamayoshi, S. et al. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. EClinicalMedicine 32, 100734 (2021).","journal-title":"EClinicalMedicine"},{"key":"828_CR9","doi-asserted-by":"crossref","unstructured":"Adeniji. O. S. et al. COVID-19 severity is associated with differential antibody Fc-mediated innate immune functions. mBio 12, e00281-21 (2021).","DOI":"10.1128\/mBio.01244-21"},{"key":"828_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/ajcp\/aqaa123","volume":"154","author":"WS Phipps","year":"2020","unstructured":"Phipps, W. S. et al. SARS-CoV-2 antibody responses do not predict COVID-19 disease severity. Am. J. Clin. Pathol. 154, 459\u2013465 (2020).","journal-title":"Am. J. Clin. Pathol."},{"key":"828_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto, D. et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature 583, 290\u2013295 (2020).","journal-title":"Nature"},{"key":"828_CR12","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1126\/science.abd0826","volume":"369","author":"CL Hsieh","year":"2020","unstructured":"Hsieh, C. L. et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science 369, 1501\u20131505 (2020).","journal-title":"Science"},{"key":"828_CR13","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1039\/D2AN90045A","volume":"147","author":"B Giri","year":"2022","unstructured":"Giri, B. et al. Microfluidic ELISA employing an enzyme substrate and product species with similar detection properties. Analyst 147, 3118\u20133118 (2022).","journal-title":"Analyst"},{"key":"828_CR14","unstructured":"Nix, B. & Wild, D. Calibration curve-fitting. In: The Immunoassay Handbook. 2nd ed. (Nature Publishing Group, New York, NY) p. 198\u2013210; (2001)"},{"key":"828_CR15","unstructured":"Christensen R. H. B. Cumulative Link Models for Ordinal Regression with the R Package ordinal."},{"key":"828_CR16","doi-asserted-by":"crossref","unstructured":"Fay, M. P. & Shaw, P. A. Exact and asymptotic weighted logrank tests for interval censored data: the interval R Package. J. Stat. Softw. http:\/\/www.jstatsoft.org\/v36\/i02\/ (2010).","DOI":"10.18637\/jss.v036.i02"},{"key":"828_CR17","unstructured":"C. D. C. COVID Data Tracker: Trends in United States COVID-19 Hospitalizations, Deaths, Emergency Visits, and Test Positivity by Geographic Area [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2023 Jul 5]. https:\/\/covid.cdc.gov\/covid-data-tracker\/#trends_select_select_00"},{"key":"828_CR18","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"828_CR19","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","volume":"5","author":"WS Lee","year":"2020","unstructured":"Lee, W. S., Wheatley, A. K., Kent, S. J. & DeKosky, B. J. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat. Microbiol. 5, 1185\u20131191 (2020).","journal-title":"Nat. Microbiol."},{"key":"828_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-021-00523-5","volume":"6","author":"Y Yang","year":"2021","unstructured":"Yang, Y. & Du, L. SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies. Signal Transduct. Target Ther. 6, 95 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"828_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.13091","volume":"310","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt, D., Alter, G., Crotty, S. & Plotkin, S. A. Correlates of protection against SARS\u2010CoV\u20102 infection and COVID\u201019 disease. Immunol. Rev. 310, 6\u201326 (2022).","journal-title":"Immunol. Rev."},{"key":"828_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21336-8","volume":"12","author":"YC Bartsch","year":"2021","unstructured":"Bartsch, Y. C. et al. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat. Commun. 12, 1018 (2021).","journal-title":"Nat. Commun."},{"key":"828_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867716","volume":"13","author":"J Hendriks","year":"2022","unstructured":"Hendriks, J. et al. High titers of low affinity antibodies in COVID-19 patients are associated with disease severity. Front. Immunol. 13, 867716 (2022).","journal-title":"Front. Immunol."},{"key":"828_CR24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","volume":"18","author":"V Legros","year":"2021","unstructured":"Legros, V. et al. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol. Immunol. 18, 318\u2013327 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"828_CR25","doi-asserted-by":"publisher","first-page":"104208","DOI":"10.1016\/j.ebiom.2022.104208","volume":"83","author":"A Ozonoff","year":"2022","unstructured":"Ozonoff, A. et al. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. eBioMedicine 83, 104208 (2022).","journal-title":"eBioMedicine"},{"key":"828_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri.2017.106","volume":"18","author":"LL Lu","year":"2018","unstructured":"Lu, L. L., Suscovich, T. J., Fortune, S. M. & Alter, G. Beyond binding: antibody effector functions in infectious diseases. Nat. Rev. Immunol. 18, 46\u201361 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"828_CR27","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1128\/CVI.00131-10","volume":"17","author":"SA Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccin. Immunol. 17, 1055\u20131065 (2010).","journal-title":"Clin. Vaccin. Immunol."},{"key":"828_CR28","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.abg5268","volume":"372","author":"WN Voss","year":"2021","unstructured":"Voss, W. N. et al. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes. Science 372, 1108\u20131112 (2021).","journal-title":"Science"},{"key":"828_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd7114","volume":"5","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes, L. et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci. Immunol. 5, eabd7114 (2020).","journal-title":"Sci. Immunol."},{"key":"828_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijid.2021.04.080","volume":"107","author":"C Gerhards","year":"2021","unstructured":"Gerhards, C. et al. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Int. J. Infect. Dis. 107, 221\u2013227 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"828_CR31","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/cid\/ciab607","volume":"74","author":"L Grandjean","year":"2022","unstructured":"Grandjean, L. et al. Long-term persistence of spike protein antibody and predictive modeling of antibody dynamics after infection with severe acute respiratory syndrome coronavirus 2. Clin. Infect. Dis. 74, 1220\u20131229 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"828_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury, D. S. et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 27, 1205\u20131211 (2021).","journal-title":"Nat. Med."},{"key":"828_CR33","first-page":"117","volume":"122","author":"RJ Harris","year":"2005","unstructured":"Harris, R. J. Heterogeneity of recombinant antibodies: linking structure to function. Dev. Biol. 122, 117\u2013127 (2005).","journal-title":"Dev. Biol."},{"key":"828_CR34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.coviro.2021.06.005","volume":"49","author":"NK Bj\u00f6rkstr\u00f6m","year":"2021","unstructured":"Bj\u00f6rkstr\u00f6m, N. K. & Ponzetta, A. Natural killer cells and unconventional T cells in COVID-19. Curr. Opin. Virol. 49, 176\u2013182 (2021).","journal-title":"Curr. Opin. Virol."},{"key":"828_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104195","volume":"68","author":"SA Bazzi","year":"2022","unstructured":"Bazzi, S. A. et al. Longitudinal COVID-19 immune trajectories in patients with neurological autoimmunity on anti-CD20 therapy. Mult. Scler. Relat. Disord. 68, 104195 (2022).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"828_CR36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230668","volume":"220","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Memory B cell development elicited by mRNA booster vaccinations in the elderly. J. Exp. Med. 220, e20230668 (2023).","journal-title":"J. Exp. Med."},{"key":"828_CR37","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.18632\/aging.103579","volume":"12","author":"X Fang","year":"2020","unstructured":"Fang, X. et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging 12, 12493\u201312503 (2020).","journal-title":"Aging"},{"key":"828_CR38","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1172\/JCI142004","volume":"130","author":"SL Klein","year":"2020","unstructured":"Klein, S. L. et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J. Clin. Invest. 130, 6141\u20136150 (2020).","journal-title":"J. Clin. Invest."},{"key":"828_CR39","doi-asserted-by":"publisher","first-page":"e059994","DOI":"10.1136\/bmjopen-2021-059994","volume":"12","author":"JE Ebinger","year":"2022","unstructured":"Ebinger, J. E. et al. Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis. BMJ Open 12, e059994 (2022).","journal-title":"BMJ Open"},{"key":"828_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.7326\/M20-5661","volume":"174","author":"V Chopra","year":"2021","unstructured":"Chopra, V., Flanders, S. A., O\u2019Malley, M., Malani, A. N. & Prescott, H. C. Sixty-day outcomes among patients hospitalized With COVID-19. Ann. Intern. Med. 174, 576\u2013578 (2021).","journal-title":"Ann. Intern. Med."},{"key":"828_CR41","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e418","volume":"35","author":"L Liang","year":"2020","unstructured":"Liang, L. et al. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J. Korean Med Sci. 35, e418 (2020).","journal-title":"J. Korean Med Sci."},{"key":"828_CR42","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1016\/j.vaccine.2022.05.090","volume":"40","author":"E Wynberg","year":"2022","unstructured":"Wynberg, E. et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine 40, 4424\u20134431 (2022).","journal-title":"Vaccine"},{"key":"828_CR43","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/aps.2015.76","volume":"36","author":"SX Yan","year":"2015","unstructured":"Yan, S. X., Deng, X. M., Wang, Q. T., Sun, X. J. & Wei, W. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL\/MpSlac-lpr mice. Acta Pharm. Sin. 36, 1367\u20131376 (2015).","journal-title":"Acta Pharm. Sin."},{"key":"828_CR44","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"The RECOVERY Collaborative Group.","year":"2021","unstructured":"The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384, 693\u2013704 (2021).","journal-title":"N. Engl. J. Med."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00828-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T15:53:18Z","timestamp":1746201198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00828-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["828"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00828-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: Nadia Siles Alvarado: Recipient of National Consortium for Graduate Degrees for Minorities in Engineering and Science (GEM) Fellowship. Cole Maguire: Recipient of NIDA T32 Training Grant 5T32DA018926-18 for graduate student stipend and travel support for scientific conferences from the European Committee for Treatment and Research in Multiple Sclerosis. Sam Bazzi: Recipient of NIH NIAAA T32AA007471 and Fred Murphy Jones & Homer Lindsey Bruce Endowed Fellowships for graduate student stipend. Christopher DiPasquale: Vice President of Assay Development of Babson Diagnostics, Inc.; holder of stock\/stock options for Babson; salary as employee of Babson. Eric Olson: Chairman of the Board of Babson Diagnostics, Inc.; holder of stock\/stock options for Babson; salary as employee of Babson. Justin F. Rousseau: Recipient of NIH National Institute of Allergy and Infectious Diseases (NIAID) funding for another project. Stephen M. Strakowski: Recipient of NIH National Institute of Mental Health and Jassen funding for other projects and consulting fees for Sunovion, WebMD, and Meadows Mental Health Policy Institute; holds leadership role with American Brain Coalition and National Network Depression Centers. Jennifer Maynard: Recipient of grant funding from Welch Foundation, Texas Biologics, NIAID, and National Science Foundation; consulting fees from Sidley on behalf of Amgen and Genentech; and travel support for attending PEGS Protein & Antibody Engineering Summit 2023, Gordon conference on Protein Engineering 2023, and MD Anderson & UT Austin Collaborative Research Summit 2023; license holder for HexaPro (multiple non-exclusive licenses) and 3A3 antibody, specific for prefusion spike; and member of scientific advisory boards of Janux (2019\u2013present) and Releviate (2020-present). Lauren I. R. Ehrlich: Recipient of grant funding from NIAID, NIA, CPRIT, APH, and Advanced Micro Devices; travel support for attending scientific conferences from the NIH and UT Austin. Esther Melamed: Recipient of grant funding from NIAAA, Austin Public Health, Babson Diagnostics; consulting fees from Horizon, Roche, Summus; honoraria from the National Center for Health Research and American Academy of Physical Medicine and Rehabilitation; and travel support for scientific conferences from the NIH, National Center for Health Research, and American Academy of Physical Medicine and Rehabilitation. All remaining authors have no competing interests: Maisey Schuler, Dzifa Amengor, Annalee Nguyen, Rebecca Wilen, Jacob Rogers, Blaine Caslin, Melissa Abigania, Todd Triplett, Janelle Creaturo, Kerin Hurley, and Dennis Wylie.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"149"}}